http://seekingalpha.com/author/proactive-investor/instablog “Stellar expects Elsasser's experience and advice in financing junior resource companies to be a valuable asset.”
Think Stellar are selling the good doctor a bit short. With the help of google translate..
An option agreement have now been signed with Elsasser and his partner Dr Mark Hutchison, a diamond geologist, which gives Elsasser and Hutchison an exclusive access to all data of Arctic Golds diamond project until the latest June 30th,2013.
If Elsasser and Hutchison find the project of such interest and will make a takeover of 100% of the project Arctic Gold will receive 2 % royalty on all sales generated out of diamond mining of the project and 10 % of shares in the project in case it is sold with profit by Markus Elsasser or the company in which the project will be placed.
Dr. Markus Elsässer, manager of the ME-fund Pergamon (LU0179077945), which specializes in commodity stocks, sees "too much short-term anxiety In the broadcast, he discusses three chose commodity stocks. Seadrill (BMG7945E1057) is equipment for the oil industry. Alkane Resources (AU000000ALK9) is an Australian company that "the situation is better than others to exploit rare earths" Alsatian.
He thinks there will only be three non-Chinese companies able to produce rare earth before 2014: Molycorp Minerals, Lynas Corp and Alkane Resources, all of which appear in his portfolio.
However, among the other commodities Elsässer singles out are uranium, because of the continued rise in the use of nuclear power, oil, and silver. In silver he has benefited from a position in Canada-listed Silvercorp, which he bought at $3 and is now at $12.
SRZ Price at posting:
5.2¢ Sentiment: LT Buy Disclosure: Not Held
